Epidemic

Tueday, 31 March 2020, marked exactly three months since the World Health Organization, the Chinese office, was notified of incidences of pneumonia from an unknown cause. According to specialists from the Robert Koch Institute in Germany, we have not yet reached the peak of the pandemic in Europe. We hear about mild and asymptomatic cases, but also about many deaths globally.

Early reports out of China showed that elderly people and the chronically ill were most vulnerable to Covid-19. Yet an alarming number of young people in the United States have been hospitalized with severe infections. According to the Centers for Disease Control and Prevention, nearly 40% of American Covid-19 patients who were hospitalized were under 55 – and 20% were between ages 20...

Who do we listen to? Who is right? Who is balanced? How should we react to the risk of the new coronavirus?

They live in five European countries and could not be more different in age, interest or inclination. However, that made no difference. They were all infected. Some were not scared. Others were terrified. They have all gone through an experience that, without exception, has marked their lives.

In mid-April 2014, the words 'scandal', 'secret', 'drugs', and 'Roche' (the Swiss drug giant) delighted the medical press, which was quick to publish tantalizing news about the ineffectiveness of Tamiflu and the enormous amounts spent by governments in order to stock up on the drug, in preparation for possible flu epidemics.